ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe
This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the need to take daily oral tablets

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, announced the authorisation of Vocabria (cabotegravir injection and tablets) in combination with Janssen Pharmaceutical Companies of Johnson & Johnson’s Rekambys (rilpivirine injection) and Edurant (rilpivirine tablets), in the European Union, for the treatment of HIV-1 infection in adults who are virologically suppressed.

Cabotegravir injection is indicated, in combination with rilpivirine injection, for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with agents of the NNRTI and INI class. This authorisation represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the need to take daily oral tablets, following the oral initiation phase.

Tags : #LatestPharmaNewsDec21 #LatestGskNewsDec21 #TreatmentforHIV

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Fighting back against superbugs- A joint initiative by UK and India ResearchersMay 23, 2025
Archish Fertility & IVF Launches #RainbowBaby Campaign to Raise Miscarriage Awareness and Inspire HopeMay 22, 2025
Asian Hospital, Faridabad Becomes the First in the City to Launch Total Lab Automation with QuidelOrthoMay 22, 2025
Sharda Care Healthcity appoints Dr. Chirag Tandon as Director of Internal MedicineMay 22, 2025
Global Milestone in the Field of Robotic SurgeryMay 22, 2025
Medanta conducts advanced first aid training for Gurugram Traffic PoliceMay 22, 2025
When to Consult a Fertility Expert: Not Just After MarriageMay 22, 2025
Ovulation Tracking: A Doctor’s Guide to Doing It RightMay 22, 2025
Debunking IVF Myths: What Doctors SayMay 22, 2025
Aster CMI Hospital Becomes India’s Largest Pediatric Liver Transplant Program Under Affordable Transplant InitiativeMay 21, 2025
Point-of-care health technologies make a difference when deployed at point-of-needMay 21, 2025
Remidio Launches its new device ‘Pristine’, Innovating AI-Powered Eye Diagnostics with Dual Brand Strategy May 21, 2025
HCGMCC & SunAct Launch North Maharashtra’s 1st Centre Of Excellence In Cell & Gene TherapyMay 21, 2025
Transforming dementia support through technology networkMay 21, 2025
Endometriosis: The Pain You Shouldn’t IgnoreMay 21, 2025
The Best Age to Freeze Your Eggs — Doctor’s AdviceMay 21, 2025
Managing PCOS Without Birth Control: Fact or Fiction?May 21, 2025
Hormonal Acne in Women: It’s Not Just CosmeticMay 21, 2025
Is Spotting Between Periods Normal?May 21, 2025
QNET India Launches #BuzzForEarth Campaign on World Bee DayMay 20, 2025